These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 23653325)

  • 1. Parkinson's disease cybrids, differentiated or undifferentiated, maintain morphological and biochemical phenotypes different from those of control cybrids.
    Appukuttan TA; Ali N; Varghese M; Singh A; Tripathy D; Padmakumar M; Gangopadhyay PK; Mohanakumar KP
    J Neurosci Res; 2013 Jul; 91(7):963-70. PubMed ID: 23653325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SH-SY5Y human neuroblastoma cell line: in vitro cell model of dopaminergic neurons in Parkinson's disease.
    Xie HR; Hu LS; Li GY
    Chin Med J (Engl); 2010 Apr; 123(8):1086-92. PubMed ID: 20497720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RA Differentiation Enhances Dopaminergic Features, Changes Redox Parameters, and Increases Dopamine Transporter Dependency in 6-Hydroxydopamine-Induced Neurotoxicity in SH-SY5Y Cells.
    Lopes FM; da Motta LL; De Bastiani MA; Pfaffenseller B; Aguiar BW; de Souza LF; Zanatta G; Vargas DM; Schönhofen P; Londero GF; de Medeiros LM; Freire VN; Dafre AL; Castro MA; Parsons RB; Klamt F
    Neurotox Res; 2017 May; 31(4):545-559. PubMed ID: 28155214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison between proliferative and neuron-like SH-SY5Y cells as an in vitro model for Parkinson disease studies.
    Lopes FM; Schröder R; da Frota ML; Zanotto-Filho A; Müller CB; Pires AS; Meurer RT; Colpo GD; Gelain DP; Kapczinski F; Moreira JC; Fernandes Mda C; Klamt F
    Brain Res; 2010 Jun; 1337():85-94. PubMed ID: 20380819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of serum concentration in retinoic acid and phorbol ester induced differentiation of SH-SY5Y human neuroblastoma cell line.
    Magalingam KB; Radhakrishnan AK; Somanath SD; Md S; Haleagrahara N
    Mol Biol Rep; 2020 Nov; 47(11):8775-8788. PubMed ID: 33098048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of all-trans-retinoic acid on human SH-SY5Y neuroblastoma as in vitro model in neurotoxicity research.
    Cheung YT; Lau WK; Yu MS; Lai CS; Yeung SC; So KF; Chang RC
    Neurotoxicology; 2009 Jan; 30(1):127-35. PubMed ID: 19056420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative Characterization of Phenotypical Markers After Differentiation of SH-SY5Y Cells.
    Ducray AD; Wiedmer L; Herren F; Widmer HR; Mevissen M
    CNS Neurol Disord Drug Targets; 2020; 19(8):618-629. PubMed ID: 32640966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical characterization of proliferative and differentiated SH-SY5Y cell line as a model for Parkinson's disease.
    Alrashidi H; Eaton S; Heales S
    Neurochem Int; 2021 May; 145():105009. PubMed ID: 33684546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylglyoxal increases dopamine level and leads to oxidative stress in SH-SY5Y cells.
    Xie B; Lin F; Peng L; Ullah K; Wu H; Qing H; Deng Y
    Acta Biochim Biophys Sin (Shanghai); 2014 Nov; 46(11):950-6. PubMed ID: 25274329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxic Effects of 3,4-Catechol-PV (One Major MDPV Metabolite) on Human Dopaminergic SH-SY5Y Cells.
    Coccini T; Vecchio S; Crevani M; De Simone U
    Neurotox Res; 2019 Jan; 35(1):49-62. PubMed ID: 29934755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential modification of dopamine transporter and tyrosine hydroxylase mRNAs in midbrain of subjects with Parkinson's, Alzheimer's with parkinsonism, and Alzheimer's disease.
    Joyce JN; Smutzer G; Whitty CJ; Myers A; Bannon MJ
    Mov Disord; 1997 Nov; 12(6):885-97. PubMed ID: 9399211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of tyrosine hydroxylase expression by melatonin in human SH-SY5Y neuroblastoma cells.
    McMillan CR; Sharma R; Ottenhof T; Niles LP
    Neurosci Lett; 2007 Jun; 419(3):202-6. PubMed ID: 17482356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of staurosporine and retinoic acid on the vulnerability of the SH-SY5Y neuroblastoma cells: involvement of bcl-2 and p53 proteins.
    Tieu K; Zuo DM; Yu PH
    J Neurosci Res; 1999 Nov; 58(3):426-35. PubMed ID: 10518116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human platelet lysate supports SH-SY5Y neuroblastoma cell proliferation and differentiation into a dopaminergic-like neuronal phenotype under xenogeneic-free culture conditions.
    Ribeiro M; Campos J; Pinho TS; Sampaio-Marques B; Barata-Antunes S; Cibrão JR; Araújo R; Duarte-Silva S; Moreira E; Sousa RA; Costa PM; Salgado AJ
    Biotechnol J; 2024 Jul; 19(7):e2400068. PubMed ID: 38987218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) inhibits neurite outgrowth in differentiating human SH-SY5Y neuroblastoma cells.
    Jung JE; Moon JY; Ghil SH; Yoo BS
    Toxicol Lett; 2009 Jul; 188(2):153-6. PubMed ID: 19446249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Constitutive expression and cytoplasmic compartmentalization of ATM protein in differentiated human neuron-like SH-SY5Y cells.
    Boehrs JK; He J; Halaby MJ; Yang DQ
    J Neurochem; 2007 Jan; 100(2):337-45. PubMed ID: 17241156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dibutyryl cyclic AMP induces differentiation of human neuroblastoma SH-SY5Y cells into a noradrenergic phenotype.
    Kume T; Kawato Y; Osakada F; Izumi Y; Katsuki H; Nakagawa T; Kaneko S; Niidome T; Takada-Takatori Y; Akaike A
    Neurosci Lett; 2008 Oct; 443(3):199-203. PubMed ID: 18691633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen-related receptor gamma regulates dopaminergic neuronal phenotype by activating GSK3β/NFAT signaling in SH-SY5Y cells.
    Lim J; Choi HS; Choi HJ
    J Neurochem; 2015 May; 133(4):544-57. PubMed ID: 25727910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcription regulator LMO4 interferes with neuritogenesis in human SH-SY5Y neuroblastoma cells.
    Vu D; Marin P; Walzer C; Cathieni MM; Bianchi EN; Saïdji F; Leuba G; Bouras C; Savioz A
    Brain Res Mol Brain Res; 2003 Jul; 115(2):93-103. PubMed ID: 12877980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effects of TRH and its analogues against various cytotoxic agents in retinoic acid (RA)-differentiated human neuroblastoma SH-SY5Y cells.
    Jaworska-Feil L; Jantas D; Leskiewicz M; Budziszewska B; Kubera M; Basta-Kaim A; Lipkowski AW; Lason W
    Neuropeptides; 2010 Dec; 44(6):495-508. PubMed ID: 20869113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.